DIRS.INFO top alerts submit data jurnalism about API
login
Top related persons:
Sage - 2 Matthew Kacsmaryk - 2 ” - 1 “ - 1 Kacsmaryk - 1 ” Sage - 1 Dr - 1 Sanjay Gupta - 1
Top related locs:
Texas “ Florida mifepristone Charlotte U.S San Francisco
Top related orgs:
Health Services Research - 2 Charlotte Lozier Institute - 2 CNN - 1 Sage Publications - 1 Chemical - 1 US - 1 Elliot Institute - 1 American Association of Pro - 1

Search resuls for: "Studnicki"


2 mentions found


☆ Journal publisher retracts studies used by Texas judge who ruled to suspend use of abortion pill
  + stars: | 2024-02-07 | by ( Jen Christensen | ) edition.cnn.com   time to read: +6 min
CNN —The academic publisher Sage Publications has retracted studies used by a Texas judge in a ruling that would suspend federal approval of the abortion pill mifepristone. The 2021 study concluded that ER visits were more likely after a medication abortion rather than a surgical abortion. Kacsmaryk cited this study to suggest that the number of adverse events from medication abortion drugs is probably under-reported. The US Supreme Court will hear arguments in March about mifepristone, one of two drugs commonly used in the US for a medication abortion. Medication abortion is the most common form of abortion in the US, and multiple peer-reviewed studies have shown that it is highly safe and effective.
Persons: Sage, ”, Matthew Kacsmaryk, “, Kacsmaryk, ” Sage, Dr, Sanjay Gupta, Jim Studnicki, Studnicki Organizations: CNN, Sage Publications, Health Services Research, Chemical, US, Charlotte Lozier Institute, Elliot Institute, American Association of Pro, CNN Health Locations: Texas, “, Florida, mifepristone, Charlotte
☆ Studies Cited in Case Over Abortion Pill Are Retracted Due to Flaws and Conflicts of Interest
  + stars: | 2024-02-07 | by ( Associated Press | Feb. | At P.M. | ) www.usnews.com   time to read: +5 min
A medical journal has retracted two studies claiming to show the harms of the abortion pill mifepristone, citing conflicts of interest by the authors and flaws in their research. Two of the three studies retracted by medical publisher Sage Perspectives were cited in a pivotal Texas court ruling that has threatened access to the pill. The U.S. Supreme Court will take up the case next month, with a decision expected later this year. Photos You Should See View All 15 ImagesBoth studies cited in the court ruling were published in the journal Health Services Research and Managerial Epidemiology. She said one of the major flaws of the retracted research is that the authors conflate ER visits with serious adverse events and don’t confirm whether patients received treatment.
Persons: —, Matthew Kacsmaryk, Sage, James Studnicki, Ivan Oransky, mifepristone Organizations: Sage, U.S, Supreme, Health Services Research, Charlotte Lozier Institute, District, New York University, University of California, FDA, Associated Press Health, Science Department, Howard Hughes Medical Institute’s Science, Educational Media Group, AP Locations: Texas, U.S, San Francisco
0 next >>
Total: 2